Jon P. Stonehouse, President & CEO at BIOCRYST PHARMACEUTICALS INC (BCRX), sold 210,000 shares at $10.38 ($2.1M) on 2023-02-01, disclosed to the SEC on 2023-02-02.
Open-market sale of $2.1M BCRX by President & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,000 | $0 | 0.0% |
| 2 | $10.38 | 100,000 | $1.0M | 50.0% |
| 3 | $10.38 | 100,000 | $1.0M | 50.0% |
| Total | $9.89 avg | 210,000 | $2.1M | 100% |
| Filing → |
| BCRX | SELL | 2022-12-02 | $4.9M | — | Filing → |
| BCRX | SELL | 2022-01-13 | $2.8M | — | Filing → |
| BCRX | SELL | 2020-12-17 | $2.2M | — | Filing → |